26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
13 °P sammeln
  • Broschiertes Buch

Objective of present study was to determine the drug utilization patterns and outcomes of treatment diabetic patients on hypoglycemic agents in the outpatient department in the tertiary care hospital. Patients with diabetes (n=168) visiting the outpatient department of a hospital who were willing to give the consent were enrolled in the study. Demographic data, Prescription predictors and other useful information were collected in case record form and then analysed. Present study was carried out with 168 patients, Majority of them belongs to type 2 diabetes having average age between 41-60…mehr

Produktbeschreibung
Objective of present study was to determine the drug utilization patterns and outcomes of treatment diabetic patients on hypoglycemic agents in the outpatient department in the tertiary care hospital. Patients with diabetes (n=168) visiting the outpatient department of a hospital who were willing to give the consent were enrolled in the study. Demographic data, Prescription predictors and other useful information were collected in case record form and then analysed. Present study was carried out with 168 patients, Majority of them belongs to type 2 diabetes having average age between 41-60 years, majority were having history of disease more than five years, with coexisting hypertension as a major complication. Patients in this setting were treated with a multiple hypoglycemic agents. The most commonly prescribed oral hypoglycemic agent was biguanides (metformin) followed by sulfonylureas (glimepiride), thiazolidinediones (pioglitazone), alpha glucosidase inhibitors (voglibose) and dipeptidyl peptidase-4 inhibitors (Sitagliptin). As monotherapy metformin was the most common choice followed by glimepiride and voglibose.
Autorenporträt
Dr. Kamal Modh,M Pharm, PhD, PGDBM&SM, is an asstistant professor in the Department of Clinical Pharmacy at Shri Sarvajanik Pharmacy College, Mehsana, Gujarat, INDIA.He has an academic research experience of over 9 years in the area of preclinical and clinical research. He had more than 13 research publications in various scientific journals.